INTS

Intensity TherapeuticsF

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-07-22

View Chart

RSI (14)

45.8

Neutral

MACD Hist

-0.02

Bearish

ATR (14)

0.27

Normal

Vol Z (20)

-1.17

Normal

RET 20D

+7.6%

Positive

Dist 52W High

-86.7%

Below High

Technical chart

1 Year

Candles, moving averages, and volume using the current RankAlpha theme.

As of 2026-07-22

Price

SMA 20

SMA 50

SMA 200

Trend readout

Technical readout

Trend

Mixed trend (SMAs not aligned)

Momentum

Short-term rebound vs weak 3M trend · 20D +7.6% · 60D -16.1%

RSI / MACD

RSI 45.8 (Neutral) · MACD hist -0.02

Volatility

Volatility muted (Z -1.17)

SMA20

4.52

SMA50

4.36

SMA200

7.48

EMA12

4.60

EMA26

4.51

BB Upper

5.20

BB Mid

4.52

BB Lower

3.85

RET 5D

-10.4%

RET 20D

+7.6%

RET 60D

-16.1%

RET 120D

-53.2%

As of 2026-07-22 • Updated nightlySource: Internal modelMethodology